- Partnership Acquires Three-Building Commercial Portfolio in Connecticut REBusiness Online
- SEC Fines Guggenheim $20M Over Exec's Undisclosed Loan Law 360 Securities
- Gautam Thakkar Named se2 CEO Marketwire - Breaking News Releases
- Sun Life Financial, Securcor Establish Securitization Program with Tetra Financial Equipment Financial Advisor
- Guggenheim Securities Receives Regulatory Approval for Its Acquisition of Former Lazard Capital Mark PR Newswire
- KBBO Group and Guggenheim Partners Announce Joint Venture PR Newswire
- Endo completes acquisition of DAVA Pharmaceuticals Pharmaceutical Business Review
- Endo to acquire Dava Pharmaceuticals Clinical Trials Today [CenterWatch]
- Endo's $600M DAVA Deal Provides Case Study In Pharma M&A Law 360 Corporate Finance
- Endo to buy DAVA Pharma to boost generics business Fidelity - Merger and Acquision News
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on GUGGENHEIM PARTNERS
- Rate GUGGENHEIM PARTNERS on their payment behavior
- Ask your network about GUGGENHEIM PARTNERS with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.